Search

everythinglearnresearchcommunity

for

Search:↓

Transferosomes effectively deliver drugs through the skin, improving treatment for skin disorders.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Adding a small amount of TPGS to minoxidil can help hair growth, but too much TPGS reduces this effect and increases minoxidil in the blood.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Effective treatments for trichotillomania include cognitive-behavioral therapy, certain medications, and alternative support tools.

Active transdermal technologies in cosmetics help deliver skin treatments effectively, but their safety and effectiveness depend on skin type and treatment choice.

The study found that Temporal Triangular Alopecia often starts in early childhood, mainly affects the left side of the scalp, and has no effective treatment except surgery.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Behavioral interventions, especially habit reversal training, are most effective for treating trichotillomania in children.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

TAK-279 effectively reduces psoriasis symptoms and is safe.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Thrombospondin-1 is crucial for hair follicle regression and reduced blood vessel growth during the catagen phase.

Transdermal delivery systems show promise for treating hair loss by delivering drugs directly through the skin.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

Mesotherapy involves injecting substances like dutasteride, minoxidil, and vitamins into the skin to treat hair loss and skin conditions, with good patient satisfaction but possible skin inflammation.

Excessive scalp massage after using minoxidil can cause hair damage, but reducing massage and using MSC exosomes can help.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

Dissolving microneedles improve the delivery of traditional Chinese medicine by making it easier, safer, and more effective.

A 3-year-old boy was diagnosed with a rare, non-scarring hair loss condition called temporal triangular alopecia.

Temporal triangular alopecia is a non-scarring hair loss in children, often linked to other health conditions.

N-acetylcysteine and memantine are recommended as safe and effective treatments for trichotillomania.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

AI-enhanced smart patches can personalize drug delivery for better treatment outcomes.